Busy specialty practice with 5 physicians. Specializing in high blood pressure and kidney disease. Currently running a Procrit Clinic for approx. 100 patients with anemia in CKD.
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. For more than three decades, HMC has been dedicated to delivering the safest, most effective and compassionate care to all its patients. HMC manages twelve hospitals – nine specialist hospitals and three community hospitals – as well as the National Ambulance Service and home and residential care services. In January 2016, HMC achieved the significant distinction of becoming the first healthcare system across the globe to have all its hospitals accredited by Joint Commission International under the Academic Medical Center accreditation program. Additionally, the National Ambulance Service, Home Healthcare Service, Stroke Service and Palliative Care, have all received this prestigious accreditation since 2011. To meet the needs of a rapidly growing population, HMC has announced ambitious plans to expand capacity across its network through to 2030. HMC is leading the development of the region’s first academic health system – combining innovative research, top-class education and excellent clinical care – and is committed to building a legacy of healthcare expertise in Qatar. HMC collaborates with key partners who are experts in Qatar and beyond, including Weill Cornell Medical College-Qatar, the Institute for Healthcare Improvement and Partners Healthcare, Boston. HMC is also the first hospital system in the Middle East to achieve institutional accreditation from the Accreditation Council of Graduate Medical Education – International (ACGME-I), which demonstrates excellence in the way medical graduates are trained through residency, internship and fellowship programs. For more information about working at HMC, please visit www.hmc.org.qa/en/employees_careers/employees_careers.aspx
Security & Compliance Standards Overview
Hypertension & Nephrology, Inc. has 21.95% more incidents than the average of same-industry companies with at least one recorded incident.
No incidents recorded for Hamad Medical Corporation in 2025.
Hypertension & Nephrology, Inc. cyber incidents detection timeline including parent company and subsidiaries
Hamad Medical Corporation cyber incidents detection timeline including parent company and subsidiaries
Last 3 Security & Risk Events by Company
NXLog Agent before 6.11 can load a file specified by the OPENSSL_CONF environment variable.
uriparser through 0.9.9 allows unbounded recursion and stack consumption, as demonstrated by ParseMustBeSegmentNzNc with large input containing many commas.
A vulnerability was detected in Mayan EDMS up to 4.10.1. The affected element is an unknown function of the file /authentication/. The manipulation results in cross site scripting. The attack may be performed from remote. The exploit is now public and may be used. Upgrading to version 4.10.2 is sufficient to fix this issue. You should upgrade the affected component. The vendor confirms that this is "[f]ixed in version 4.10.2". Furthermore, that "[b]ackports for older versions in process and will be out as soon as their respective CI pipelines complete."
MJML through 4.18.0 allows mj-include directory traversal to test file existence and (in the type="css" case) read files. NOTE: this issue exists because of an incomplete fix for CVE-2020-12827.
A half-blind Server Side Request Forgery (SSRF) vulnerability exists in kube-controller-manager when using the in-tree Portworx StorageClass. This vulnerability allows authorized users to leak arbitrary information from unprotected endpoints in the control plane’s host network (including link-local or loopback services).
